Debra K. Liebert

Investing Profile

Fund: $163.6M

Domain Associates thesis

FOUNDED IN 1985 FOUNDED IN 1985 FOUNDED IN 1985 FOUNDED IN 1985 INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS $2.8 Billion assets managed VC funding of 194 biopharm, device and diagnostic companies 90 IPOs 110 M&A events $190 Billion market cap of funded companies Click for More Info and Portfolio Team Members James Blair, Partner Brian Dovey, Partner (In Memorium 2023) Brian Halak, Partner Kim Kamdar, Partner Jesse Treu, Partner Emeritus Nicole Vitullo, Partner Kathleen Schoemaker, Partner and CFO (In Memorium 2016) Lisa Krae

Sector and stage focus

  • Seed: Pharmaceuticals, BioTech, Health IT, Health & Hospital Services
  • Series B: BioTech, Pharmaceuticals, Health & Hospital Services, Health IT
  • general: Diverse Investors, Female Investors, Los Angeles / Southern California
  • Series A: Pharmaceuticals, Health IT, BioTech, Health & Hospital Services

Recent investments by Debra K. Liebert

Debra K. Liebert has 2 named past investments in the public record. The most recent:

Company Stage Date Round size
Sonexa Therapeutics Series A Jan 2008 $30M
Milestone Pharmaceuticals Series C Aug 2017 $55M

Frequent co-investors

Debra K. Liebert has co-invested with: Marco Boorsma, Eric Linsley, Ela Borenstein, Kim P. Kamdar, Louis Bock.

Is Debra K. Liebert a fit for your round?

Upload your pitch deck and see whether Debra K. Liebert appears in your top 20 matches.

Find investors for your deck